These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27318613)

  • 21. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor structure of the Montreal Cognitive Assessment items in a sample with early Parkinson's disease.
    Benge JF; Balsis S; Madeka T; Uhlman C; Lantrip C; Soileau MJ
    Parkinsonism Relat Disord; 2017 Aug; 41():104-108. PubMed ID: 28572020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pill questionnaire in a nondemented Parkinson's disease population.
    Reginold W; Armstrong MJ; Duff-Canning S; Lang A; Tang-Wai D; Fox S; Rothberg B; Zadikoff C; Kennedy N; Gill D; Eslinger P; Mapstone M; Chou K; Persad C; Litvan I; Mast B; Marras C
    Mov Disord; 2012 Sep; 27(10):1308-11. PubMed ID: 22865587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.
    Brown DS; Bernstein IH; McClintock SM; Munro Cullum C; Dewey RB; Husain M; Lacritz LH
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):264-72. PubMed ID: 26177715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive profile of the earliest stage of dementia in Parkinson's disease.
    Petrova M; Raycheva M; Traykov L
    Am J Alzheimers Dis Other Demen; 2012 Dec; 27(8):614-9. PubMed ID: 22992299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
    Serrano-Dueñas M; Calero B; Serrano S; Serrano M; Coronel P
    Mov Disord; 2010 Nov; 25(15):2555-62. PubMed ID: 20824734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research consent capacity varies with executive function and memory in Parkinson's disease.
    Moelter ST; Weintraub D; Mace L; Cary M; Sullo E; Xie SX; Karlawish J
    Mov Disord; 2016 Mar; 31(3):414-7. PubMed ID: 26861463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.
    Zgaljardic DJ; Borod JC; Foldi NS; Mattis P
    Cogn Behav Neurol; 2003 Dec; 16(4):193-210. PubMed ID: 14665819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations for interpreting failure on individual subtests of the Montreal Cognitive Assessment.
    Moafmashhadi P; Koski L
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):19-28. PubMed ID: 23385364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.
    Nie K; Zhang Y; Wang L; Zhao J; Huang Z; Gan R; Li S; Wang L
    J Clin Neurosci; 2012 Nov; 19(11):1497-500. PubMed ID: 22959678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. French translation and normation of the Parkinson Neuropsychometric Dementia Assessment (PANDA).
    Gasser AI; Kalbe E; Calabrese P; Kessler J; Von Allmen G; Rossier P
    J Neurol Sci; 2011 Nov; 310(1-2):189-93. PubMed ID: 21764080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
    Doiron M; Langlois M; Dupré N; Simard M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of lifelong cognitive lifestyle on executive function in older people with Parkinson's disease.
    Hindle JV; Martin-Forbes PA; Martyr A; Bastable AJM; Pye KL; Mueller Gathercole VC; Thomas EM; Clare L
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):e157-e165. PubMed ID: 28170111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
    Hoogland J; de Bie RM; Williams-Gray CH; Muslimović D; Schmand B; Post B
    Mov Disord; 2010 Nov; 25(15):2550-4. PubMed ID: 20878993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parkinson disease and cognition].
    Kulisevsky J; Pascual-Sedano B
    Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Fraraccio M; Ptito A; Sadikot A; Panisset M; Dagher A
    Arch Clin Neuropsychol; 2008 Jul; 23(4):399-408. PubMed ID: 18394859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration and cognition in Parkinson's disease: a review.
    Ding W; Ding LJ; Li FF; Han Y; Mu L
    Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2275-81. PubMed ID: 26166654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of EEG slowing with cognitive domains in nondemented patients with Parkinson's disease.
    Zimmermann R; Gschwandtner U; Hatz F; Schindler C; Bousleiman H; Ahmed S; Hardmeier M; Meyer A; Calabrese P; Fuhr P
    Dement Geriatr Cogn Disord; 2015; 39(3-4):207-14. PubMed ID: 25591733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.